Literature DB >> 24446511

Improved lesion formation using the novel 28 mm cryoballoon in atrial fibrillation ablation: analysis of biomarker release.

Stefano Bordignon1, Alexander Fürnkranz1, Daniela Dugo1, Laura Perrotta1, Melanie Gunawardene1, Frank Bode2, Anne Klemt1, Bernd Nowak1, Britta Schulte-Hahn1, Boris Schmidt1, K R Julian Chun3.   

Abstract

AIMS: Recently, a novel second-generation (G2) cryoballoon (CB) was introduced. Comparative analysis of lesion formation in terms of myocardial biomarker release [first-generation CB (G1) vs. G2] has not been studied. To compare myocardial biomarker release using the 28 mm G1 vs. G2 CB. METHODS AND
RESULTS: In patients (patients) treated with the simplified single big CB (SBCB) strategy for pulmonary vein isolation (PVI), myocardial biomarkers [troponin T (TnT), creatine kinase, lactic dehydrogenase (LDH)] were measured at 12, 24, and 48 h after PVI. Two groups were defined: Group 1 (G1; freezing time: 300 s), Group 2 (G2; freezing time: 240 s). Mean biomarker peak values were compared. To correct for between-group differences in cumulative freezing time, an index calculated as peak biomarker release divided by cumulative freezing time was calculated. Sixty-six CB PVI procedures (G1: 33 patients, G2: 33 patients) were analysed. Pulmonary vein isolation was achieved in all the patients using the simplified SBCB technique only. Mean freezing time (51 ± 10 vs. 33 ± 6 min, P < 0.01) was significantly shorter in G2. All biomarker levels tended to be higher in G2 vs. G1. The indexed biomarkers values were significantly higher in G2: TnT: 18.8 ± 8.5 vs. 32.3 ± 13.6 pg/L/min (P < 0.01); creatinephosphokinase: 6.7 ± 2.7 vs. 11.7 ± 3.9 U/L/min (P < 0.01); LDH: 5.2 ± 1.0 vs. 9.1 ± 2.7 U/L/min (P < 0.01). On a 6-month follow-up (180 days), G2 revealed a significantly higher success rate (20/33 vs. 28/33; P = 0.027).
CONCLUSION: Pulmonary vein isolation using the G2 CB increased the myocardial biomarker release index and is linked to a significantly improved 6 months success rate. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2014. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Atrial fibrillation; Cardiac biomarker; Cryoablation

Mesh:

Substances:

Year:  2014        PMID: 24446511     DOI: 10.1093/europace/eut400

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  8 in total

1.  Outcome of paroxysmal atrial fibrillation ablation with the cryoballoon using two different application times: the 4- versus 3-min protocol.

Authors:  Florian Straube; Uwe Dorwarth; Stefan Hartl; Benedikt Bunz; Michael Wankerl; Ullrich Ebersberger; Ellen Hoffmann
Journal:  J Interv Card Electrophysiol       Date:  2015-12-23       Impact factor: 1.900

2.  Efficacy, High Procedural Safety And Rapid Optimization Of Cryoballoon Atrial Fibrillation Ablation In The Hands Of A New Operator.

Authors:  Eberhard Scholz; Patrick Lugenbiel; Patrick A Schweizer; Panagiotis Xynogalos; Claudia Seyler; Edgar Zitron; Rüdiger Becker; Hugo A Katus; Dierk Thomas
Journal:  J Atr Fibrillation       Date:  2016-02-29

Review 3.  Outcomes Of Cryoballoon Ablation Of Atrial Fibrillation: A Comprehensive Review.

Authors:  Arash Aryana; Mark R Bowers; Padraig Gearoid O'Neill
Journal:  J Atr Fibrillation       Date:  2015-08-31

4.  Acute procedural and cryoballoon characteristics from cryoablation of atrial fibrillation using the first- and second-generation cryoballoon: a retrospective comparative study with follow-up outcomes.

Authors:  Arash Aryana; Shemsa Morkoch; Sean Bailey; Hae W Lim; Rahmani Sara; André d'Avila; P Gearoid O'Neill
Journal:  J Interv Card Electrophysiol       Date:  2014-09-17       Impact factor: 1.900

5.  Procedural Safety and Efficacy for Pulmonary Vein Isolation with the Novel Polarx™ Cryoablation System: A Propensity Score Matched Comparison with the Arctic Front™ Cryoballoon in the Setting of Paroxysmal Atrial Fibrillation.

Authors:  Joerelle Mojica; Felicia Lipartiti; Maysam Al Housari; Gezim Bala; Shuichiro Kazawa; Vincenzo Miraglia; Cinzia Monaco; Ingrid Overeinder; Antanas Strazdas; Robbert Ramak; Gaetano Paparella; Juan Sieira; Lucio Capulzini; Antonio Sorgente; Erwin Stroker; Pedro Brugada; Carlo De Asmundis; Gian-Battista Chierchia
Journal:  J Atr Fibrillation       Date:  2021-06-30

6.  Prediction of mid-term outcome after cryo-balloon ablation of atrial fibrillation using post-procedure high-sensitivity troponin level.

Authors:  Tolga Aksu; Sukriye Ebru Golcuk; Tümer Erdem Guler; Kivanç Yalin; Ismail Erden
Journal:  Cardiovasc J Afr       Date:  2015-03-17       Impact factor: 1.167

7.  Hemoptysis after five months of cryoballoon ablation: What is the relationship?

Authors:  Keita Watanabe; Junichi Nitta; Akira Sato; Masahiko Goya; Mitsuaki Isobe; Kenzo Hirao
Journal:  HeartRhythm Case Rep       Date:  2017-05-31

8.  High-sensitive cardiac troponin T as a predictor of efficacy and safety after pulmonary vein isolation using focal radiofrequency, multielectrode radiofrequency and cryoballoon ablation catheter.

Authors:  Ivan Zeljkovic; Sven Knecht; Nikola Pavlovic; Umut Celikyrut; Florian Spies; Sarah Burri; Dominik Mannhart; Loris Peterhans; Tobias Reichlin; Beat Schaer; Stefan Osswald; Christian Sticherling; Michael Kuhne
Journal:  Open Heart       Date:  2019-04-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.